Table 2 Pituitary hormone function at baseline in the study population (n = 101) and association with different parameters
Number of pituitary hormone deficiencies (at baseline) | Gender | p-value | |
Males (n = 62) | Females (n = 39) | ||
 • 0 | 12 (19.4%) | 12 (41.6%) | 0.06 |
 • 1–2 | 24 (38.7%) | 17 (43.5%) | |
 • ≥3 | 26 (41.9%) | 10 (25.6%) | |
Individual hormone axis | |||
 • GH deficiency | 43 (63.4%) | 17 (43.5%) | 0.01* |
 • LH/FSH deficiency | 37 (59.7%) | 18 (21.2%) | 0.22 |
 • ACTH deficiency | 22 (35.3%) | 11 (28.2%) | 0.52 |
 • TSH deficiency | 24 (38.7%) | 12 (30.8%) | 0.52 |
Number of pituitary hormone deficiencies (at baseline) | Age at Surgery (mean ± SD)/ years | p-value | |
 • 0 | 54.7 ± 13.0 | 0.001* | |
 • 1–2 | 57.7 ± 12.0 | ||
 • ≥3 | 63.8 ± 11.6 | ||
Individual hormone axis | Age at Surgery (mean ± SD)/ years | p-value | |
 • GH deficiency | 60.6 ± 11.6 | 0.16 | |
 • LH/FSH deficiency | 63.5 ± 11.0 | < 0.01* | |
 • ACTH deficiency | 63.2 ± 13.2 | 0.03* | |
 • TSH deficiency | 62.2 ± 12.0 | 0.06 | |